These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8739603)

  • 1. Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication.
    Diabata M; Enzinger EM; Monroe JE; Kilkuskie RE; Field AK; Mulder C
    Antiviral Res; 1996 Mar; 29(2-3):243-60. PubMed ID: 8739603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
    Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demethylation of the Epstein-barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent. Brief report.
    Falk KI; Ernberg I
    Arch Virol; 1999; 144(11):2219-27. PubMed ID: 10603176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.
    Yao GQ; Grill S; Egan W; Cheng YC
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1420-5. PubMed ID: 8395789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
    Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
    J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells.
    Roth G; Curiel T; Lacy J
    Blood; 1994 Jul; 84(2):582-7. PubMed ID: 8025284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.
    Kudoh A; Fujita M; Kiyono T; Kuzushima K; Sugaya Y; Izuta S; Nishiyama Y; Tsurumi T
    J Virol; 2003 Jan; 77(2):851-61. PubMed ID: 12502801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
    Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
    Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.
    Li Y; Long X; Huang L; Yang M; Yuan Y; Wang Y; Delecluse HJ; Kuang E
    J Virol; 2016 Jan; 90(2):887-903. PubMed ID: 26537683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.
    Inman GJ; Binné UK; Parker GA; Farrell PJ; Allday MJ
    J Virol; 2001 Mar; 75(5):2400-10. PubMed ID: 11160743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
    J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
    Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
    J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression.
    Yang EV; Webster Marketon JI; Chen M; Lo KW; Kim SJ; Glaser R
    Brain Behav Immun; 2010 Oct; 24(7):1089-96. PubMed ID: 20466055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.
    Shimizu N; Takada K
    J Virol; 1993 Jun; 67(6):3240-5. PubMed ID: 8388498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.
    Prang N; Wolf H; Schwarzmann F
    J Virol; 1995 Apr; 69(4):2644-8. PubMed ID: 7884918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain variation in Epstein-Barr virus immediate early genes.
    Packham G; Brimmell M; Cook D; Sinclair AJ; Farrell PJ
    Virology; 1993 Feb; 192(2):541-50. PubMed ID: 8093650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A concatenated form of Epstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1.
    Cho MS; Tran VM
    Virology; 1993 Jun; 194(2):838-42. PubMed ID: 8389085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
    Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
    Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.